The "Checkpoint Inhibitor Refractory Cancer Drugs Market -- Growth, Share, Opportunities & Competitive Analysis, 2025 -- 2032" report has been added to the Credence Research Inc. offering. The global ...

Pioneering clinical trial testing how personalised mRNA vaccines can enable the immune system to target recurring pancreatic cancer.

On a typical day, they greet farmers bringing them ticks, real estate agents with mysterious roaches and anxious homeowners ...

Both countries experience health challenges related to displacement. The Gaza conflict (2023–2025) in Israel led to outbreaks of scabies, hepatitis A, and multidrug-resistant infections among ...

Reflecting on a session from last week’s Nuffield Trust Summit on misinformation and polarised views about health, Leonora Merry discusses the growing gap between experts, institutions and the public ...

Nebraska Cancer Specialists has opened a new clinic on the second floor of the Prairie Commons Medical Office building. Nebraska Cancer Specialists will host an open house from noon to 2 p.m. Friday, ...

Researchers launch a public immune atlas of pancreatic cancer therapy responses, allowing the public to rapidly link pancreatic cancer immunotherapy trials to immune shifts and outcomes. Imagine ...

Small choices—from phone communication to sedation protocols—can ease the euthanasia experience for families while helping ...

Lydia Love, DVM, DACVAA, shares practice safety tips including build psychological safety and use checklists to trap errors ...

The market for radioligand therapies is expected to grow significantly in the coming years. This is due to the increasing number of patients who are being ...

Capturing Unicorns: Targeting Cancers With TP53 Mutations, RAS Alterations Beyond G12C, and MTAP Loss—No Target Is Out of the Realm of Possibility Bispecific antibodies (bsAbs) have emerged as a novel ...